Trial Profile
Toyama antihypertensive therapy with Olmesartan in Post-Stroke patients (TOPS) study
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 31 Jan 2013
Price :
$35
*
At a glance
- Drugs Olmesartan medoxomil (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- Acronyms TOPS
- 31 Jan 2013 New trial record